{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T23:37:41Z","timestamp":1793230661696,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/j.kint.2024.10.018","type":"journal-article","created":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T01:24:41Z","timestamp":1731029081000},"page":"198-211","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Lupus nephritis: redefining the treatment goals"],"prefix":"10.1016","volume":"107","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9596-8529","authenticated-orcid":false,"given":"An S.","family":"De Vriese","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4536-7709","authenticated-orcid":false,"given":"Sanjeev","family":"Sethi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9952-209X","authenticated-orcid":false,"given":"Fernando C.","family":"Fervenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.kint.2024.10.018_bib1","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.kint.2016.05.017","article-title":"A pathophysiology-based approach to the diagnosis and treatment of lupus nephritis","volume":"90","author":"Anders","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2024.10.018_bib2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41572-019-0141-9","article-title":"Lupus nephritis","volume":"6","author":"Anders","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.kint.2024.10.018_bib3","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.kint.2021.09.012","article-title":"The lupus nephritis management renaissance","volume":"101","author":"Mejia-Vilet","year":"2022","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2024.10.018_bib4","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1136\/annrheumdis-2020-216965","article-title":"Lack of EULAR\/ERA-EDTA response at 1 year predicts poor long-term renal outcome in patients with lupus nephritis","volume":"79","author":"Moroni","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.kint.2024.10.018_bib5","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2215\/CJN.05040513","article-title":"Renal flare as a predictor of incident and progressive CKD in patients with lupus nephritis","volume":"9","author":"Parikh","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.10.018_bib6","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1681\/ASN.2016070776","article-title":"A proposal for a serology-based approach to membranous nephropathy","volume":"28","author":"De Vriese","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.10.018_bib7","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/annrheumdis-2020-216924","article-title":"2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR\/ERA-EDTA) recommendations for the management of lupus nephritis","volume":"79","author":"Fanouriakis","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.kint.2024.10.018_bib8","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2023.09.002","article-title":"KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS","volume":"105","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2024.10.018_bib9","first-page":"1500","article-title":"Deep remission within 12 months prevents renal flare and damage accrual in lupus nephritis","volume":"41","author":"Kikuchi","year":"2023","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.kint.2024.10.018_bib10","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1002\/art.37940","article-title":"Comparison of alternative primary outcome measures for use in lupus nephritis clinical trials","volume":"65","author":"Wofsy","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.kint.2024.10.018_bib11","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1002\/art.39026","article-title":"Predictors of long-term renal outcome in lupus nephritis trials: lessons learned from the Euro-Lupus Nephritis cohort","volume":"67","author":"Dall\u2019Era","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/j.kint.2024.10.018_bib12","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2015-000123","article-title":"A proteinuria cut-off level of 0.7 g\/day after 12 months of treatment best predicts long-term renal outcome in lupus nephritis: data from the MAINTAIN Nephritis Trial","volume":"2","author":"Tamirou","year":"2015","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.kint.2024.10.018_bib13","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1053\/j.ajkd.2016.01.030","article-title":"Membranous nephropathy: a journey from bench to bedside","volume":"68","author":"Francis","year":"2016","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2024.10.018_bib14","doi-asserted-by":"crossref","first-page":"445","DOI":"10.2215\/CJN.06010809","article-title":"Mycophenolate mofetil for induction and maintenance of remission in microscopic polyangiitis with mild to moderate renal involvement\u2014a prospective, open-label pilot trial","volume":"5","author":"Silva","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.10.018_bib15","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1093\/ckj\/sfac150","article-title":"Kidney biopsy in lupus nephritis after achieving clinical renal remission: paving the way for renal outcome assessment","volume":"15","author":"Lledo-Ibanez","year":"2022","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.kint.2024.10.018_bib16","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.kint.2019.07.018","article-title":"Kidney biopsy-based management of maintenance immunosuppression is safe and may ameliorate flare rate in lupus nephritis","volume":"97","author":"Malvar","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2024.10.018_bib17","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1093\/rheumatology\/keaa129","article-title":"Per-protocol repeat kidney biopsy portends relapse and long-term outcome in incident cases of proliferative lupus nephritis","volume":"59","author":"Parodis","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.kint.2024.10.018_bib18","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/j.kint.2018.05.021","article-title":"A prospective observational cohort study highlights kidney biopsy findings of lupus nephritis patients in remission who flare following withdrawal of maintenance therapy","volume":"94","author":"De Rosa","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2024.10.018_bib19","doi-asserted-by":"crossref","first-page":"ii19","DOI":"10.1093\/ckj\/sfad232","article-title":"Microscopic hematuria as a risk factor for IgAN progression: considering this biomarker in selecting and monitoring patients","volume":"16","author":"Zand","year":"2023","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.kint.2024.10.018_bib20","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/106904","article-title":"The value of a panel of autoantibodies for predicting the activity of lupus nephritis at time of renal biopsy","volume":"2015","author":"Moroni","year":"2015","journal-title":"J Immunol Res"},{"key":"10.1016\/j.kint.2024.10.018_bib21","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2215\/CJN.13431021","article-title":"The use of serological tests in the care of patients with lupus nephritis","volume":"17","author":"Ayoub","year":"2022","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.10.018_bib22","first-page":"288","article-title":"Systemic lupus erythematosus disease activity index 2000","volume":"29","author":"Gladman","year":"2002","journal-title":"J Rheumatol"},{"key":"10.1016\/j.kint.2024.10.018_bib23","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.cca.2021.12.029","article-title":"Laboratory evaluation of anti-dsDNA antibodies","volume":"528","author":"Cockx","year":"2022","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.kint.2024.10.018_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2023-001012","article-title":"Clinical implications of discordance between anti-dsDNA antibodies by multiplex flow immunoassay and Crithidia luciliae assay in a multiethnic racial cohort of patients with SLE","volume":"10","author":"Zaminski","year":"2023","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.kint.2024.10.018_bib25","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1177\/0961203316645205","article-title":"Anti-C1q in systemic lupus erythematosus","volume":"25","author":"Stojan","year":"2016","journal-title":"Lupus"},{"key":"10.1016\/j.kint.2024.10.018_bib26","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1136\/ard-2022-223808","article-title":"Machine learning identifies clusters of longitudinal autoantibody profiles predictive of systemic lupus erythematosus disease outcomes","volume":"82","author":"Choi","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.kint.2024.10.018_bib27","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2022-000834","article-title":"Autoantibody-based subgroups and longitudinal seroconversion in juvenile-onset systemic lupus erythematosus","volume":"10","author":"Bao","year":"2023","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.kint.2024.10.018_bib28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.clim.2016.08.001","article-title":"Lupus nephritis biomarkers","volume":"185","author":"Soliman","year":"2017","journal-title":"Clin Immunol"},{"key":"10.1016\/j.kint.2024.10.018_bib29","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s13075-017-1442-6","article-title":"Predictive biological markers of systemic lupus erythematosus flares: a systematic literature review","volume":"19","author":"Gensous","year":"2017","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.kint.2024.10.018_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2023.103165","article-title":"Proximity extension assay proteomics and renal single cell transcriptomics uncover novel urinary biomarkers for active lupus nephritis","volume":"143","author":"Li","year":"2024","journal-title":"J Autoimmun"},{"key":"10.1016\/j.kint.2024.10.018_bib31","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1681\/ASN.2019121285","article-title":"Urinary soluble CD163: a novel noninvasive biomarker of activity for lupus nephritis","volume":"31","author":"Mejia-Vilet","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.10.018_bib32","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.172569","article-title":"Urine proteomic signatures of histological class, activity, chronicity, and treatment response in lupus nephritis","volume":"9","author":"Fava","year":"2024","journal-title":"JCI Insight"},{"key":"10.1016\/j.kint.2024.10.018_bib33","doi-asserted-by":"crossref","first-page":"e168","DOI":"10.1016\/S2665-9913(23)00320-X","article-title":"Mycophenolate mofetil withdrawal in patients with systemic lupus erythematosus: a multicentre, open-label, randomised controlled trial","volume":"6","author":"Chakravarty","year":"2024","journal-title":"Lancet Rheumatol"},{"key":"10.1016\/j.kint.2024.10.018_bib34","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1136\/annrheumdis-2022-222435","article-title":"Weaning of maintenance immunosuppressive therapy in lupus nephritis (WIN-Lupus): results of a multicentre randomised controlled trial","volume":"81","author":"Jourde-Chiche","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.kint.2024.10.018_bib35","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1093\/rheumatology\/keac225","article-title":"Low-dose glucocorticoids withdrawn in systemic lupus erythematosus: a desirable and attainable goal","volume":"62","author":"Ji","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.kint.2024.10.018_bib36","doi-asserted-by":"crossref","first-page":"79","DOI":"10.3899\/jrheum.110532","article-title":"Frequency of class III and IV nephritis in systemic lupus erythematosus without clinical renal involvement: an analysis of predictive measures","volume":"39","author":"Wakasugi","year":"2012","journal-title":"J Rheumatol"},{"key":"10.1016\/j.kint.2024.10.018_bib37","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/rheumatology\/keab373","article-title":"Immunosuppressive therapy withdrawal after remission achievement in patients with lupus nephritis","volume":"61","author":"Zen","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.kint.2024.10.018_bib38","first-page":"S75","article-title":"What happens after complete withdrawal of therapy in patients with lupus nephritis","volume":"31","author":"Moroni","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.kint.2024.10.018_bib39","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/rheumatology\/kead231","article-title":"SMART-SLE: serology monitoring and repeat testing in systemic lupus erythematosus\u2014an analysis of anti-double-stranded DNA monitoring","volume":"63","author":"Yeo","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.kint.2024.10.018_bib40","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1681\/ASN.2013111233","article-title":"ANCA as a predictor of relapse: useful in patients with renal involvement but not in patients with nonrenal disease","volume":"26","author":"Kemna","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.10.018_bib41","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.3899\/jrheum.100007","article-title":"Prolonged serologically active clinically quiescent systemic lupus erythematosus: frequency and outcome","volume":"37","author":"Steiman","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/j.kint.2024.10.018_bib42","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.1002\/art.22198","article-title":"The effect of moderate-dose corticosteroids in preventing severe flares in patients with serologically active, but clinically stable, systemic lupus erythematosus: findings of a prospective, randomized, double-blind, placebo-controlled trial","volume":"54","author":"Tseng","year":"2006","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.kint.2024.10.018_bib43","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/S0140-6736(95)90114-0","article-title":"Prevention of relapses in systemic lupus erythematosus","volume":"345","author":"Bootsma","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2024.10.018_bib44","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1038\/s41591-022-02017-5","article-title":"Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus","volume":"28","author":"Mackensen","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.kint.2024.10.018_bib45","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1056\/NEJMoa2001180","article-title":"Two-year, randomized, controlled trial of belimumab in lupus nephritis","volume":"383","author":"Furie","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2024.10.018_bib46","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1681\/ASN.2008101028","article-title":"Mycophenolate mofetil versus cyclophosphamide for induction treatment of lupus nephritis","volume":"20","author":"Appel","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.10.018_bib47","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1016\/S0140-6736(21)00578-X","article-title":"Efficacy and safety of voclosporin versus placebo for lupus nephritis (AURORA 1): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial","volume":"397","author":"Rovin","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2024.10.018_bib48","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1136\/annrheumdis-2021-220920","article-title":"B-cell depletion with obinutuzumab for the treatment of proliferative lupus nephritis: a randomised, double-blind, placebo-controlled trial","volume":"81","author":"Furie","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.kint.2024.10.018_bib49","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1177\/0961203307083443","article-title":"Long-term outcome of Chinese patients with membranous lupus nephropathy","volume":"17","author":"Sun","year":"2008","journal-title":"Lupus"},{"key":"10.1016\/j.kint.2024.10.018_bib50","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1681\/ASN.2008060665","article-title":"Randomized, controlled trial of prednisone, cyclophosphamide, and cyclosporine in lupus membranous nephropathy","volume":"20","author":"Austin","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.10.018_bib51","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1681\/ASN.2014070640","article-title":"Anti-phospholipase A2 receptor antibody titer predicts post-rituximab outcome of membranous nephropathy","volume":"26","author":"Ruggenenti","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.10.018_bib52","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2215\/CJN.06460622","article-title":"Maintenance of remission and risk of relapse in myeloperoxidase-positive ANCA-associated vasculitis with kidney involvement","volume":"18","author":"Casal Moura","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2024.10.018_bib53","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.kint.2017.11.023","article-title":"Revision of the International Society of Nephrology\/Renal Pathology Society classification for lupus nephritis: clarification of definitions, and modified National Institutes of Health activity and chronicity indices","volume":"93","author":"Bajema","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2024.10.018_bib54","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2023-000932","article-title":"Remission of lupus nephritis: the trajectory of histological response in successfully treated patients","volume":"10","author":"Malvar","year":"2023","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.kint.2024.10.018_bib55","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2014-000018","article-title":"Role of early repeated renal biopsies in lupus nephritis","volume":"1","author":"Zickert","year":"2014","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.kint.2024.10.018_bib56","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1093\/ndt\/gfv296","article-title":"Histologic versus clinical remission in proliferative lupus nephritis","volume":"32","author":"Malvar","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2024.10.018_bib57","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1136\/annrheumdis-2012-202844","article-title":"Prospective observational single-centre cohort study to evaluate the effectiveness of treating lupus nephritis with rituximab and mycophenolate mofetil but no oral steroids","volume":"72","author":"Condon","year":"2013","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.kint.2024.10.018_bib58","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1093\/ndt\/gfr517","article-title":"Strategy for second kidney biopsy in patients with lupus nephritis","volume":"27","author":"Alsuwaida","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2024.10.018_bib59","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1177\/0961203313518625","article-title":"The value of repeat kidney biopsy in quiescent Argentinian lupus nephritis patients","volume":"23","author":"Alvarado","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.kint.2024.10.018_bib60","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1177\/0961203321995251","article-title":"Correlation between the clinical remission and histological remission in repeat biopsy findings of quiescent proliferative lupus nephritis","volume":"30","author":"Das","year":"2021","journal-title":"Lupus"},{"key":"10.1016\/j.kint.2024.10.018_bib61","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1136\/ard-2023-224762","article-title":"EULAR recommendations for the management of systemic lupus erythematosus: 2023 update","volume":"83","author":"Fanouriakis","year":"2024","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.kint.2024.10.018_bib62","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s40697-014-0030-9","article-title":"The steroid in the maintenance of remission of proliferative lupus nephritis (SIMPL) pilot trial","volume":"1","author":"Galbraith","year":"2014","journal-title":"Can J Kidney Health Dis"},{"key":"10.1016\/j.kint.2024.10.018_bib63","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.kint.2020.11.009","article-title":"Induction and maintenance therapy of lupus nephritis: an obituary","volume":"99","author":"Anders","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2024.10.018_bib64","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1093\/ndt\/gfy024","article-title":"Preemptive immunosuppressive treatment for asymptomatic serological reactivation may reduce renal flares in patients with lupus nephritis: a cohort study","volume":"34","author":"Yap","year":"2019","journal-title":"Nephrol Dial Transpl"},{"key":"10.1016\/j.kint.2024.10.018_bib65","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/ndt\/gfad154","article-title":"Chronic kidney disease: the missing concept in the 2019 EULAR\/ERA-EDTA recommendations for lupus nephritis","volume":"39","author":"Rojas-Rivera","year":"2023","journal-title":"Nephrol Dial Transplant"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253824007816?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253824007816?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,22]],"date-time":"2025-01-22T15:20:48Z","timestamp":1737559248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253824007816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2]]},"references-count":65,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S0085253824007816"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2024.10.018","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lupus nephritis: redefining the treatment goals","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2024.10.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}